학술논문
Golidocitinib in Treating Refractory or Relapsed Peripheral T- Cell Lymphoma: Full Analysis of the Multinational Pivotal Study Results (JACKPOT8)
Document Type
Abstract
Author
Song, Yuqin ; Malpica, Luis ; Cai, Qingqing ; Zhao, Weili ; Zhou, Keshu ; Wu, Jianqiu ; Zhang, Huilai ; Ding, Kaiyang ; Liu, Yao ; Li, Zengjun ; Mehta-Shah, Neha ; Zhang, Liling ; Zheng, Meifang ; Jin, Jie ; Yang, Haiyan ; Shuang, Yuerong ; Yoon, Dok Hyun ; Gao, Sujun ; Li, Wenyu ; Zhai, Zhimin ; Zou, Liqun ; Xi, Yaming ; Koh, Youngil ; Li, Fei ; Prince, Miles ; Zhou, Hui ; Lin, Lie ; Liu, Hui ; Yang, Zhenfan ; Kim, Won Seog ; Zhu, Jun
Source
In Blood 2 November 2023 142 Supplement 1:305-305
Subject
Language
ISSN
0006-4971
Abstract
Disclosures Mehta-Shah:Karyopharm Therapeutics: Consultancy; Celgene: Research Funding; Daiichi Sankyo: Consultancy, Research Funding; Kyowa Hakko: Consultancy; Janssen: Consultancy; Corvus Pharmaceuticals: Research Funding; C4 Therapeutics: Consultancy, Research Funding; Genentech/Roche: Research Funding; Bristol Myers-Squibb: Research Funding; AstraZeneca: Consultancy, Research Funding; Innate Pharmaceuticals: Research Funding; Ono Pharmaceuticals: Consultancy; Secura Bio/Verastem: Consultancy, Research Funding; Genentech: Consultancy. Yoon:Janssen: Consultancy, Honoraria, Research Funding, Speakers Bureau; Takeda: Honoraria, Speakers Bureau; Kirin Pharm: Honoraria, Speakers Bureau; Boryung: Research Funding; BMS: Honoraria, Speakers Bureau; Roche: Honoraria, Research Funding, Speakers Bureau; Pharos iBio: Consultancy; Beigene: Consultancy; Abclon: Consultancy; Samyang: Research Funding; Novartis: Consultancy, Honoraria, Speakers Bureau; GI cell: Consultancy; GC cell: Consultancy. Koh:Sanofi Genzyme: Research Funding; Proteina: Current holder of stock options in a privately-held company; Curocell: Current equity holder in private company; Deep Metrics: Current equity holder in private company; Novartis Korea: Consultancy; Takeda Korea: Consultancy; BMS Korea: Consultancy; Genome Opinion: Current Employment, Current equity holder in private company, Membership on an entity's Board of Directors or advisory committees; Tomocube: Current holder of stock options in a privately-held company, Membership on an entity's Board of Directors or advisory committees; Janssen Korea: Consultancy. Prince:Takeda: Speakers Bureau; Mallinkrodt: Speakers Bureau; Mundipharma: Speakers Bureau; Merck: Speakers Bureau. Yang:Dizal Pharmaceutical: Current Employment. Kim:Donga: Research Funding; Boryung: Research Funding; Sanofi: Research Funding; Roche: Research Funding; Kyowa-Kirin: Research Funding; Beigene: Research Funding. [Display omitted]